What is it about?
We searched for a simple and cost effective diagnostic tool that may predict a future Alzheimer's disease at a very early stage, to allow clinicians to adopt therapeutic measures as soon as possible
Featured Image
Why is it important?
Alzheimer's disease is one of the most challenging medical battles for future years. To diagnose it at very early disease stages is mandatory to adopt really effective therapeutic strategies that can modify the disease course. A cost effective but reliable diagnostic tool is necessary for future clinical trials testing for new experimental drugs.
Perspectives
I think this work might represent a useful step to elaborate a simple diagnostic tool that could be useful in future clinical trials. Further studies with larger and independent samples of patients are needed to validate these preliminary data
Dr Roberto Santangelo
Ospedale San Raffaele
Read the Original
This page is a summary of: Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer’s Disease Dementia, Journal of Alzheimer s Disease, October 2016, IOS Press,
DOI: 10.3233/jad-160360.
You can read the full text:
Contributors
The following have contributed to this page
